USPTO serial 79450803
FELDAN SHUTTLE
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHAN, AHSEN M
- Law office
- TMO LAW OFFICE 113
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with FELDAN SHUTTLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, chronic wound, skin cancer, precancerous skin lesions, skin fibrosis and treatment of acne; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases, disorders and infections; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), parkinson's disease, multiple sclerosis, myasthenia gravis, huntington's disease; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia and obesity; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in the treatment of musculoskeletal diseases and disorders; pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; cardiovascular pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma; dermatological pharmaceutical preparations for the treatment of psoriasis; dermatological pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the diagnosis of oncological diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations. | ACTIVE | — |
| 042 | Pharmaceutical research and development; research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, dermatology, oncology, cardiology, gastroenterology, endocrinology, genitourinary, ophthalmology, nephrology, pulmonology, vascular system, and ischemia; providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, dermatology, oncology, cardiology, gastroenterology, endocrinology, genitourinary, ophthalmology, nephrology, pulmonology, vascular system, and ischemia; drug discovery services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 28, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |